One dose of synthetic psilocybin in combination with psychotherapy significantly reduces treatment-resistant depression associated with bipolar II disorder (BDII), a small, nonrandomized clinical ...

Bipolar disorder (BD) is a psychiatric disorder characterized by extreme mood changes. Individuals diagnosed with BD ...

Synthetic psilocybin with psychotherapy was effective and safe for patients with treatment-resistant bipolar depression, a small nonrandomized controlled trial suggested. Among 15 people with bipolar ...

It is well-proven that cannabis use is associated with an increased risk of schizophrenia and heavy use of high-THC marijuana is associated with four times the normal rate of schizophrenia (see my ...

A recent Nutrients journal study reviews the potential beneficial effects of the ketogenic diet (KD) on anxiety, depression, stress, schizophrenia, and bipolar disorder. Study: The Potential Effects ...

A brain rhythm working in tandem with the body's natural sleep-wake cycle may explain why bipolar patients alternate between mania and depression, according to new research. A new study marks a ...

Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be used ...

Baylor College of Medicine received nearly $10 million in funding from the NIH BRAIN Initiative to study effective treatments for the depressive phase of bipolar disorder. In the span of five years, ...

Exterior photo of the Mayo Building, which houses the University of Minnesota Medical School's Twin Cities campus. NINA MOINI: An estimated 7 million adults in the US live with bipolar disorder, a ...